A pragmatic randomized controlled trial of the usefulness of Chinese medicine in the treatment of pulmonary nodules
- Conditions
- Pulmonary nodules
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Age 18-80 years.
(2) Karnofsky score =90.
(3) Less than 15 mm pure ground glass/solid component less than 15 mm partially solid pulmonary nodules.
(4) Basic normal function of heart, liver, kidney and hematopoietic system.
(5) Voluntary participation in this study and signed informed consent.
(1) Total number of pulmonary nodules = 10.
(2) Patients considered to have pulmonary nodular disease, tuberculosis, intrapulmonary lymph nodes, malignancy, sclerosing angioma, sarcoidosis, or lymphoma.
(3) Current symptoms suggestive of lung cancer: unexplained weight loss of more than 6.5 kg in the past 12 months, or unexplained hemoptysis.
(4) Patients undergoing treatment with targeted, immune, chemotherapy, radiotherapy, etc.
(5) Patients who are receiving anti-inflammatory therapy or within 1 month of the end of anti-inflammatory therapy.
(6) Patients whose imaging of non-first detected nodules suggests that the nodules are progressing or resorbing
(7) Patients who are children, pregnant women, psychiatric patients, and patients with tumors that have not undergone radical surgery.
(8) Patients who are taking other drugs or health food that have an effect on this trial.
(9) Those who are participating in other clinical trials.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean diameter of target nodule;Computer calculated volume;Mean diameter of solid components;CT Value;The Effective Rate;
- Secondary Outcome Measures
Name Time Method Evaluation of TCM syndrome;Assessment of anxiety state;